Pfizer’s Bourla: State of US Presidential Transition Not ‘Ideal’ For Vaccine Rollout

 
• By Sarah Karlin-Smith
Pfizer CEO Albert Bourla discussed the company's COVID-19 vaccine on 17 November • Source: STAT Summit

More from Distribution/Supply Chain

More from Compliance